Compare Qurate Retail Inc Series A (QVCAQ) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Qurate Retail Inc Series A vs Regeneron Pharmaceuticals Inc — how do they compare? Qurate Retail Inc Series A trades at $0.04 (market cap $653.75K), while Regeneron Pharmaceuticals Inc trades at $653.5 (market cap $70.79B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 108283× Qurate Retail Inc Series A's market cap, and Regeneron Pharmaceuticals Inc pays a 0.56% dividend while Qurate Retail Inc Series A pays none. Which is the better fit depends on your goals.
| QVCAQ | REGN | |
|---|---|---|
Market Cap | $653.75K | $70.79B |
Sector | Consumer Cyclical | Health |
52-Week High | $15.03 | $812.27 |
52-Week Low | $0.05 | $545.46 |
Enterprise Value | $4.73B | $64.74B |
Dividend Yield | — | 0.56% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Qurate Retail Inc Series A
Qurate Retail Inc, through its subsidiaries, is engaged in the video and online commerce industries. Its segments include QxH, which includes QVC U.S. and HSN market and sell a wide variety of consumer products in the United States, primarily using their televised shopping programs and via the Internet through their websites and mobile applications
Read more on QVCAQ →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
